Logo
HEMOPHILIA GENE THERAPY MARKET ANALYSIS
  2. / Market Insights
  3. Hemophilia Gene Therapy Market Analysis
We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.
all report title image

HEMOPHILIA GENE THERAPY MARKET ANALYSIS

Hemophilia Gene Therapy Market, by Hemophilia Type (Hemophilia A and Hemophilia B), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

  • Published In : Aug 2022
  • Code : CMI2480
  • Pages :110
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

Leading Companies

Key Players

Major players operating in the global hemophilia gene therapy market include BioMarin Pharmaceuticals, Inc., Spark Therapeutics, Pfizer, Inc., UniQure NV, Ultragenyx Pharmaceutical, Shire PLC Sangamo Therapeutics, Inc., and Freeline Therapeutics.

Companies covered:

BioMarin Pharmaceuticals, Inc., Spark Therapeutics, Pfizer, Inc., UniQure NV, Ultragenyx Pharmaceutical, Shire, Sangamo Therapeutics Inc., and Freeline Therapeutics. 

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now

Press Release

Hemophilia Gene Therapy Market to Surpass US$ 2,197.9 Mn by 2030
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.